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Abstract
Dietary fish oil modifies skeletal muscle membrane fatty acid composition and oxygen efficiency similar to
changes in the myocardium. Oxygen efficiency is a key determinant of sustained force in mammalian skeletal
muscle. Therefore, in the present study, we tested the effects of a fish-oil diet on skeletal muscle fatigue under
the stress of contraction using the rat in vivo autologous perfused hindlimb model. For 8 weeks, male Wistar
rats were fed a diet rich in saturated fat (SF), a diet rich in n-6 PUFA or a diet rich in long-chain (LC) n-3
PUFA DHA derived from fish oil. In anaesthetised, mechanically ventilated rats, with their hindlimbs
perfused with arterial blood at a constant flow, the gastrocnemius–plantaris–soleus muscle bundle was
stimulated via sciatic nerve (2 Hz, 6–12 V, 0·05 ms) to contract repetitively for 30 min. Rats fed the n-3 PUFA
diet developed higher maximum twitch tension than those fed the SF and n-6 PUFA diets (P< 0·05) and
sustained twitch tension through more repetitions before the tension declined to 50 % of the maximum twitch
tension (P< 0·05). The n-3 PUFA group used less oxygen for tension developed and produced higher venous
lactate concentrations with no difference in glycogen utilisation compared with the SF and n-6 PUFA groups.
These results further support that incorporation of DHA into skeletal muscle membranes increases the
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Abstract
Dietary fish oil modifies skeletal muscle membrane fatty acid composition and oxygen efficiency similar to changes in the myocardium.
Oxygen efficiency is a key determinant of sustained force in mammalian skeletal muscle. Therefore, in the present study, we tested the
effects of a fish-oil diet on skeletal muscle fatigue under the stress of contraction using the rat in vivo autologous perfused hindlimb
model. For 8 weeks, male Wistar rats were fed a diet rich in saturated fat (SF), a diet rich in n-6 PUFA or a diet rich in long-chain (LC)
n-3 PUFA DHA derived from fish oil. In anaesthetised, mechanically ventilated rats, with their hindlimbs perfused with arterial blood at
a constant flow, the gastrocnemius–plantaris–soleus muscle bundle was stimulated via sciatic nerve (2 Hz, 6–12 V, 0·05 ms) to contract
repetitively for 30 min. Rats fed the n-3 PUFA diet developed higher maximum twitch tension than those fed the SF and n-6 PUFA diets
(P,0·05) and sustained twitch tension through more repetitions before the tension declined to 50 % of the maximum twitch tension
(P,0·05). The n-3 PUFA group used less oxygen for tension developed and produced higher venous lactate concentrations with no differ-
ence in glycogen utilisation compared with the SF and n-6 PUFA groups. These results further support that incorporation of DHA into
skeletal muscle membranes increases the efficiency of oxygen use over a range of contractile force and this is expressed as a higher
sustained force and prolonged time to fatigue.
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Skeletal muscle fatigue, or the decline in expectant force
development, is tightly coupled with oxygen supply and
demand(1–4). The ability of skeletal muscle to rapidly adjust
developed forcewhenoxygen is limiting or demand is increased
is well established and associated with reduced muscle function
without disturbance in tissue levels of ATP(5). Therefore, effi-
cient use of available oxygen is of upmost importance with
regard to repetitive and sustained skeletal muscle force
production.
Structural membrane composition directly affects cell func-
tion(6). When long-chain (LC) n-3 PUFA from dietary fish oil
are incorporated into myocardial membranes(7–10), the func-
tion of the heart is enhanced, particularly when oxygen
supply is compromised(8,11). In skeletal muscle membranes,
a similar process of incorporation occurs, whereby LC n-3
PUFA DHA concentrations are well above the dietary or circu-
lating concentrations(10,12–14). A number of key metabolic(15)
and physiological(16) processes have been reported to be
associated with the increased concentrations of LC n-3 PUFA
DHA in skeletal muscle membranes.
Preliminary evidence has emerged that skeletal muscle
oxygen consumption is modulated, as in the heart, after fish
oil supplementation. In trained cyclists, dietary fish oil
supplementation, delivering high concentrations of DHA,
has been shown to reduce heart rate and whole-body
oxygen consumption during prolonged submaximal cycling
performance(17). Skeletal muscle is the dominant consumer
of oxygen during intense exercise, and this implies that the
efficiency of oxygen use by the working muscles is enhanced.
To directly test this hypothesis, oxygen consumption has been
measured across autoperfused contracting hindlimbs(18).
Incorporation of DHA into skeletal muscle membranes results
in oxygen cost-saving effects, as observed in the heart. How-
ever, oxygen consumption has been measured at only one
time point in the fatigue process. Muscle fatigue commences
from the initiation of force production, and in light of the
critical role of oxygen supply and demand, this detailed
relationship deserves further investigation.
No clear improvement in human fatigue tolerance has yet
been demonstrated with dietary fish oil(19–21). This can be
attributed either to varying n-3 PUFA doses and durations of
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supplementation(22) or to fatigue measures with poor
reliability and sensitivity. The latter can largely be ascribed
to the focus of research on potential cardiac, peripheral vascu-
lar or haematological mechanisms for improved exercise
endurance. In other words, whole-body exercise tolerance is
multifactorial, and unless careful design is employed, the
many underlying mechanisms as to why one cannot
sustain exercise, including the properties of skeletal muscle
itself, cannot be resolved. Specifically, with regard to our
oxygen modulation hypothesis, neither human(17) nor
animal(14) studies have primarily been designed to directly
examine the effects of LC n-3 PUFA on muscle endurance,
focusing instead on cardiac endurance and on the recovery
of skeletal muscle contractile force between repeat contractile
bouts. Moreover, a previous study has employed a muscle
stimulation rate too slow and of insufficient duration to elicit
a major depression in skeletal muscle force production and
thus enable an objective measure of muscle fatigue.
To date, no attempt has been made to investigate the
direct impact of fish oil supplementation and specifically
incorporation of LC n-3 DHA into skeletal muscle membranes
on prolonged contractile fatigue resistance. Therefore, the aim
of the present study was to use the autologous blood-perfused
hindlimb method in rats(18,23) to investigate the effects of
dietary LC n-3 PUFA, and specifically DHA, on skeletal muscle
fatigue resistance including measuring oxygen consumption at
multiple time points of force depression. It was hypothesised
that the increased efficiency of skeletal muscle oxygen con-
sumption, at multiple time points, would be expressed as an
attenuation of muscle force depression over a sustained bout
of contraction eliciting fatigue.
Experimental methods
In total, eighteen young male Wistar rats (400–500 g; 18–20
weeks of age) were used for the study and were evenly
divided into groups of six per dietary intervention. The rats
were housed two per cage in the animal facility of the Univer-
sity of Wollongong with temperature being maintained at
23–258C under a 12 h light–dark cycle. Experiments were
assessed and approved by the Animal Ethics Committee of
the University of Wollongong, and all national and institutional
guidelines were followed.
Diet composition
In the present study, three diets (saturated fat (SF), n-6 PUFA
and n-3 PUFA) were prepared. All the diets contained a
balanced mix of macro- and micronutrients to avoid any nutri-
ent deficiencies based on the AIN-93M diet(24). In brief, the
diets were designed to deliver (1) similar total PUFA amounts
in the n-6 PUFA (36·65 g/kg) and n-3 PUFA (31·40 g/kg) diets,
(2) similar n-6 PUFA amounts in the n-3 PUFA (5·01 g/kg) and
SF (4·77 g/kg) diets and (3) similar n-3 PUFA amounts in the
n-6 PUFA (0·49 g/kg) and SF (0·58 g/kg) diets. Olive oil was
used as a light (refined) oil; thus, the diets were free of con-
founding sources of natural antioxidants; beef tallow was
used as saturated fat; safflower oil as a source of n-6 PUFA;
high-DHA tuna fish oil as a source of n-3 PUFA (a-linolenic
acid 0·56 g/kg, EPA 4·87 g/kg and DHA 20·2 g/kg) (Nu-Mega
Ingredients). All the diets contained 10 % fat by weight. The
proportions of fat sources have been reported previously(14):
the SF diet contained 30:70 olive oil and beef tallow; the n-6
PUFA diet contained 50:50 olive oil and safflower oil; the n-3
PUFA diet contained 30:70 olive oil and tuna oil. The diets were
prepared from purified ingredients and stored at 2208C(25).
Study design
The rats were fed a washout diet containing olive oil for 14 d
to standardise muscle membrane fatty acid composition. The
eighteen rats were then randomly allocated to three groups
and fed the SF, safflower oil (n-6 PUFA) or tuna fish-oil (n-3
PUFA) diet for 8 weeks (ad libitum). Fresh food was provided
twice per week, and daily intake was estimated by weighing
the remainder from the previous feeding. The weight of the
rats was measured once per week.
Surgical preparation for ventilation, muscle perfusion
and stimulation
The autologous pump-perfused hindlimb method has been
described previously in both canines(26) and rats(14,23). In
brief, rats (18–20 weeks) were anaesthetised (sodium pento-
barbital 6 mg/100 g intraperitoneally) with supplementary
injections (2 mg/100 g intraperitoneally) as required. The
experiments were carried with each of the rats and the per-
fusion system being enclosed in a heated Perspex chamber
(32·2 ^ 0·38C) with the body temperature of the rats being
maintained at 378C (rectal temperature). The specific diet
group that each rat belonged to was blinded to the scientist
carrying out the procedure. The rats were prepared for artifi-
cial ventilation (1 ml/100 g body weight, Rodent Ventilator
7025; Ugo Basile) and blood pressure recording by intubation
of the trachea and cannulation of the left carotid artery,
respectively.
All cannulae were fluid filled with saline containing 6 %
dextran (w/v) and 5000 IU heparin/100 ml (Sigma-Aldrich).
Arterial (oxygenated) blood was accessed via a cannula
inserted into the right femoral artery (non-perfused leg)
towards the heart and was connected to a resealing flexi-
tube, passed through a peristaltic roller pump (Minipuls 3;
Gilson). Arterial blood was then passed through a cannula
inserted into the left femoral artery (perfused leg) and posi-
tioned to deliver blood directly to muscle groups below the
knee. A T-junction inserted in the blood flow line on the
perfused hindlimb side of the pump was connected to a press-
ure transducer (Argon CDXIII; Maxim Medical) for the
measurement of hindlimb perfusion pressure. The return of
deoxygenated venous blood to the heart and lungs was
achieved via passive flow through a cannula inserted
into the left femoral vein of the perfused leg and the right
jugular vein.
Hindlimb muscle contraction was achieved via sciatic nerve
stimulation. A bipolar electrode (F-B5EI; Grass Technologies)
was placed under the nerves for direct electrical stimulation

















of the trunk supplying the muscles of the gastrocnemius–
plantaris–soleus muscle bundle. The nerve was crushed
above the stimulation point to prevent retrograde
conduction, standard practice in hindlimb experiments(27).
The gastrocnemius–plantaris–soleus muscle group tendons
were tied with non-compliant silk and connected to a force
transducer (FT03C; Grass Technologies). Saline-soaked
gauze was placed over the muscles to prevent drying.
Hindlimb perfusion and stimulation protocol
The hindlimbs of the rats were perfused for 30 min at 1 ml/min
with no stimulation to allow for perfusion pressure to reach
steady state (approximately 100 mmHg), and then baseline
arterial and venous blood samples (200ml) were drawn. The
flow rate was reset and maintained at 2 ml/min during
a single 30 min repetitive twitch stimulation bout (2 Hz,
7–12 V, 0·05 ms) to the sciatic nerve. Venous samples were
collected throughout the stimulation bout period at time
points 30 s, 60 s, 2·5 min and 5 min and then every 5 min
until 30 min.
Measurements
Blood pressure and twitch force. Data were referenced to
ground and amplified (Onspot Australia). The data acquisition
software (Labview for Windows; National Instruments) was
used to collect perfusion pressure and twitch force data
throughout the perfusion trials (sampling rate 200 Hz).
Twitch characteristics were analysed at time points corre-
sponding to blood sampling. Developed tension and other
characteristics were averaged from ten consecutive contrac-
tions. Peak tension was defined as the highest developed
force in each twitch curve. Maximal peak twitch tension was
defined as the mean tension over the ten highest peak ten-
sions. The first derivative of developed tension was used to
determine the maximum rate of developed tension and relax-
ation. The area under the twitch curve (tension–time index)
was calculated relative to peak tension at the point of initial
contraction (first ten contractions), at the point of maximum
contraction (maximal ten contractions) and after 30 min of
contraction (final ten contractions).
Blood samples. Arterial and venous blood samples
(200ml) were collected via resealing silicone sections of the
cannulae located proximal and distal to the hindlimbs. Of
the 200ml blood sampled, 80ml were used for the measure-
ment of PO2, PCO2, Na
þ, Kþ, pH and Hb using the laboratory
blood gas and electrolyte machine (ABL77; Radiometer). The
remaining 120ml were spun down on a benchtop microcentri-
fuge (Millipore), and the plasma was removed and frozen for
later analysis of blood glucose and lactate. Erythrocytes from
the plasma samples were resuspended in an equal volume
of saline and re-injected into the venous side of the perfusion.
Hb concentrations were maintained above 12·5 g/100 ml
whole blood throughout the experiments.
Muscle samples. Control muscle samples (gastrocnemius,
plantaris and soleus) were collected from the right (non-
perfused) leg immediately before the right femoral artery
cannulation to be used as within-animal control tissue. At
the completion of each trial and while the blood was still
flowing, left leg (perfused and contracted) muscle samples
(gastrocnemius, plantaris and soleus) were rapidly extracted.
All the muscles were freeze-clamped and stored (2808C) for
later analysis. Soleus muscle was sampled as red/oxidative
tissue and gastrocnemius muscle was sampled as white/
glycolytic tissue. Additional muscle samples (deep posterior
tibial, extensor digitorum longus and tibialis anterior) from
the perfused hindlimbs were collected to determine the total
wet weight of the skeletal muscle involved in the perfusion.
Statistical analysis
Two-way ANOVA was conducted with diet and time main
effects and diet £ time interaction using Statistix, version 8
(Analytical Software). Individual dietary pairwise comparisons
were made using a corrected Bonferroni post hoc analysis for
multiple comparisons of individual means. a was set at
P,0·05. Data are expressed as means with their standard
errors.
Results
Food consumption and body weight
There was no significant difference in the quantity of food
consumed between the dietary groups at either the start or
the end of the trials or in the mean daily intake (SF: 6·68
(0·20 SEM) g/100 g body weight per d; n-6 PUFA: 6·54 (0·15
SEM) g/100 g body weight per d; n-3 PUFA: 6·37 (0·13 SEM)
g/100 g body weight per d) over the 8-week feeding period.
The mean body weight of the n-6 PUFA group (544 (35
SEM) g) was higher than that of the SF (465 (28 SEM) g) and
n-3 PUFA (472 (34 SEM) g) groups (P,0·05). There were no
significant differences in the wet weight of the gastrocne-
mius–plantaris–soleus muscle bundle, which represented
the contracting skeletal muscle bundle, between the dietary
groups (SF: 3·08 (0·21 SEM) g wet weight; n-6 PUFA: 2·93
(0·17 SEM) g wet weight; n-3 PUFA: 2·51 (0·23 SEM) g wet
weight).
Baseline perfusion
Stable baseline conditions were achieved in all the dietary
groups (Table 1). Rectal temperature was equally well main-
tained during all the surgical procedures and experimental
conditions in all the dietary groups (SF: 37·0 ^ 0·98C; n-6
PUFA: 36·7 ^ 0·68C; n-3 PUFA: 36·0 ^ 0·78C). There was no
significant difference in hindlimb perfusion pressure following
30 min of controlled flow (1 ml/min) (SF: 109 (11 SEM) mmHg;
n-6 PUFA: 102 (3 SEM) mmHg; n-3PUFA: 106 (6 SEM) mmHg).
In all the dietary groups, artificial ventilation (SF: 151 (12
SEM) ml/min; n-6 PUFA: 172 (13 SEM) ml/min; n-3 PUFA: 147
(11 SEM) ml/min) and resulting PaO2 were sufficient to achieve
approximately 98 % oxygen saturation of erythrocytes and cor-
responding high content of arterial oxygen (approximately
19–20 ml/100 ml). Baseline venous PO2 was significantly

















lower than arterial PO2 (P,0·05), demonstrating basal oxygen
consumption by the resting muscle bundle. There was no
effect of diet on the (a 2 v) O2 difference or basal oxygen
consumption. There were no differences in the basal blood
lactate or glucose concentrations between the dietary groups.
Tension development and oxygen consumption
In all the dietary groups, twitch tension increased from the
tension developed in the first twitch to reach maximum
twitch tension after about 150 contractions (60–80 s). Peak
twitch tension then gradually declined over the course of
30 min repetitive stimulation bouts (Fig. 1(a); P,0·05). The
n-3 PUFA group developed significantly greater maximum
twitch tension and attained greater peak tensions throughout
the stimulation period (P,0·05). There was no difference in
time from initial twitch to the twitch of maximum tension
(Fig. 2(a)) or in time from the twitch of maximum tension to
the twitch of 80 % maximum tension between the dietary
groups (Fig. 2(b)). However, in the n-3 PUFA group, the
peak twitch tension took longer time to decline to 50 % of
the maximum compared with that in the SF and n-6 PUFA
groups, with the difference being significantly different from
that in the n-6 PUFA group (P,0·05).
Oxygen consumption increased with time during the repeti-
tive stimulation bouts in all the groups (P,0·05 for time) and
stabilised after about 10 min of contractions (Fig. 1(b)). It was
very similar in all the dietary groups for the first 5 min of con-
tractions. Beyond this time, the oxygen consumption of the
n-6 PUFA and SF groups stabilised, whereas that of the n-3
PUFA group continued to increase before stabilising signifi-
cantly higher after 15 min (P,0·05 for diet; Fig. 1(b)). The
decline in peak twitch tension coupled with the increased
oxygen consumption led to a decrease in the efficiency
index over time, independent of diet (P,0·05; Fig. 1(c)).
The higher oxygen consumption in the n-3 PUFA group was
associated with greater peak twitch tension in the n-3 PUFA
group throughout the stimulation period and a significantly
higher efficiency of oxygen utilisation (P,0·05; Fig. 1(c)).
The twitch characteristics such as rise time, fall time, con-
traction duration and maximum rates of tension development
and relaxation increased over the duration of the contraction
bouts (P,0·05; Fig. 3). However, the n-3 PUFA diet attenuated
the changes in twitch characteristics, resulting in significantly
faster twitch development and relaxation rates and shorter
rise time, fall time and twitch duration compared with either
the n-6 PUFA or SF diet across the 30 min of contraction
bouts (P,0·05).
Blood lactate, blood glucose and muscle glycogen
Femoral venous blood lactate concentrations increased above
the resting levels (P,0·05) during repetitive muscle contrac-
tions and venous pH decreased (P,0·05) (Fig. 1(d) and
(e)). Lactate concentrations increased rapidly initially (within
60 s) and continued to increase gradually throughout the
stimulation period. Venous lactate concentrations and pH
changes were augmented in the n-3 PUFA group and were
significantly different from those in both the n-6 PUFA and
SF groups (P,0·05).
Table 1. Baseline (non-contracting) arterial and venous blood gas and resulting oxygen
consumption following 30 min of perfusion at a constant flow rate (1 ml/min)*
(Mean values with their standard errors, n 6 per group)
SF n-6 PUFA n-3 PUFA
Mean SEM Mean SEM Mean SEM
Arterial
pH 7·52 0·02 7·54 0·02 7·54 0·02
PaO2 (mmHg) 94 3 94 3 98 4
PaCO2 (mmHg) 33 2 35 2 33 1
Hb (g/100 ml) 13·0 0·5 12·4 0·5 13·2 0·3
CaO2 (ml/100 ml) 18·3 0·6 18·0 0·6 18·6 0·4
HCO 23 concentration (mM) 26·95 1·03 30·01 1·94 29·0 1·38
Lactate concentration (mM) 1·74 0·17 1·64 0·14 1·71 0·09
Glucose concentration (mM) 5·87 0·64 5·75 0·18 6·1 0·08
Venous
pH 7·45 0·02 7·44 0·02 7·42 0·02
PvO2 (mmHg) 46 3 47 2 49 2
PvCO2 (mmHg) 42 1 45 3 40 2
Hb (g/100 ml) 13·2 0·4 12·95 0·44 13·2 0·3
CvO2 (ml/100 ml) 15·19 0·76 15·03 0·36 14·96 0·51
HCO 23 concentration (mM) 28·2 1·3 30·38 2·07 27·83 1·69
Lactate concentration (mM) 1·96 0·13 2·1 0·14 2·0 0·11
Glucose concentration (mM) 5·57 0·56 5·48 0·74 6·0 0·84
Oxygen consumption
(a 2 v) O2 (ml/100 ml) 3·14 0·51 2·95 0·52 2·96 0·23
VO2 (mmol/g £ min) 0·43 0·07 0·42 0·06 0·45 0·06
SF, saturated fat; PaO2, arterial O2 partial pressure; PaCO2, arterial CO2 partial pressure; CaO2, arterial content of
O2; HCO
2
3 , carbonate concentration; PvO2, venous O2 partial pressure; PvCO2, venous CO2 partial pressure;
CvO2, venous content of O2; (a 2 v) O2, arterial venous O2 difference; VO2, O2 consumption.
* There were no significant differences between the dietary groups for variables measured at baseline (P.0·05).

















There were no differences in arterial glucose concentrations
(SF: 5·8 (0·2 SEM) mmol/l; n-6 PUFA: 5·7 (0·3 SEM) mmol/l; n-3
PUFA: 6·1 (0·3 SEM) mmol/l) or femoral venous glucose con-
centrations (SF: 5·5 (0·2 SEM) mmol/l; n-6 PUFA: 5·5 (0·3
SEM) mmol/l; n-3 PUFA: 6·0 (0·3 SEM) mmol/l) between the
dietary groups at rest. Femoral venous glucose concentrations
did not change throughout the contraction period (30 min)
(SF: 4·8 (0·5 SEM) mmol/l; n-6 PUFA: 5·4 (0·5 SEM) mmol/l;
n-3 PUFA: 5·7 (0·6 SEM) mmol/l). Glycogen concentrations in
the stimulated muscle after 30 min of repetitive contractions
were lower than those in the control muscle (P,0·05), and
yet they were not affected by diet in either the control gastro-
cnemius muscle (SF: 9·33 (1·09 SEM) mg/g wet weight; n-6
PUFA: 9·19 (0·46 SEM) mg/g wet weight; n-3 PUFA: 8·78 (0·70
SEM) mg/g wet weight) or the stimulated gastrocnemius
muscle (SF: 6·93 (1·19 SEM) mg/g wet weight; n-6 PUFA: 6·11
(0·64 SEM) mg/g wet weight; n-3 PUFA: 5·78 (0·67 SEM) mg/g
wet weight) following 30 min of contractions. The results
obtained for glycogen were reflected in both the soleus and
the plantaris muscle (data not shown).
Discussion
In rats fed fish oil, skeletal muscle was resistant to fatigue
during repetitive twitch contractions in vivo, extending the
original observations of the modulation of VO2 in skeletal
muscle by fish oil during bouts of contraction and recovery(14),





































































































































Fig. 1. Effect of dietary fat on mean contractile and blood measures over time
in the gastrocnemius–plantaris–soleus muscle bundle during 30 min repetitive
sciatic nerve stimulation bouts (2 Hz, 7–12 V, 0·05 ms). (a) Isometric twitch
tension, (b) oxygen consumption, (c) efficiency index (tension developed per
mol O2 consumed), (d) blood lactate concentrations (symbols represent
femoral venous lactate concentrations and horizontal dashed line represents
arterial lactate concentrations) and (e) femoral venous pH. Time 0 represents
prestimulation and is not shown for twitch tension or efficiency index. Values
are means (n 6 per group), with their standard errors represented by vertical
bars which are omitted when smaller than the symbol. * Mean values were
significantly different between the dietary groups (P,0·05). † Mean values
were significantly different within the dietary groups over time (P,0·05).







































Fig. 2. Effect of dietary fat on (a) time from the first twitch to the maximum
peak twitch tension, (b) time for peak twitch tension to decline to 80 and
50 %, respectively, of the maximum (max) peak twitch tension. Values are
means (n 6 per group), with their standard errors represented by vertical
bars. * Mean value was significantly different from that of the n-6 PUFA
dietary group (P,0·05). † Mean value was significantly different from that of
the saturated fat (SF) dietary group (P,0·1).

















and in the myocardium(28). This represents an increased effi-
ciency of contraction-dependent oxygen use over a range of
force production with no dietary differences in basal VO2,
similar to that observed in the Kþ-arrested quiescent heart(28).
The fatigue process could be clearly divided into an early
phase of rapid decline in twitch tension achieved with con-
secutive contractions followed by a slow phase. In the n-3
PUFA rats, the early phase was characterised by greater con-
tractile force and a reduced rate of fatigue with no extra cost
of VO2 (increased O2 use efficiency). In contrast, there was
little difference in efficiency in the later phase of fatigue
between the dietary groups, where higher contraction force
in the n-3 PUFA rats was matched by higher VO2 and more
rapid force development and relaxation. The early rapid fati-
gue during low-frequency stimulation (in which oxidative
metabolism predominates)(29) has been attributed to meta-
bolic changes(30), which may in turn be attributable to the
accumulation of inorganic phosphate (Pi) observed in a similar
preparation of hindlimb muscle used in the present study. The
accumulation of Pi reduces Ca
2þ sensitivity and precipitates
CaPi to reduce sarcoplasmic reticulum Ca
2þ release. The sec-
ondary slowing of contraction and relaxation suggests
retarded removal of Ca2þ from the cytoplasm, which may
be attributable to poor energy efficiency powering the sarco-
plasmic reticulum ATPase or inhibition by Pi or reactive
oxygen species(31). Reduced rates of calcium release from
the sarcoplasmic reticulum into the cytosol and re-uptake by
the sarcoplasmic reticulum Ca2þ-ATPase are implicated in
muscle fatigue(32), and in the present study, DHA protection
against the fatigue-related slowing of relaxation time in turn
implicates attenuation of the impairment of cytoplasmic
Ca2þ re-uptake(33). There is a parallel with the altered cellular
Ca2þ handling implicated in many of the effects of dietary fish
oil in the heart(34), including the modulation of excessive
oxygen consumption and cardiac arrhythmias, both of which
are usually associated with conditions of cellular sarcoplasmic
reticulum and mitochondrial Ca2þ overload(28,35). The
increased efficiency has a further parallel to the reduced
whole-body VO2 throughout the prolonged exercise bouts
in trained cyclists supplemented with fish oil(17) and improved
post-ischaemic cardiac recovery in rats(28,36).
The optimal oxygenation and perfusion properties of the
in vivo autologous hindlimb model(23), adapted from canine
muscle fatigue experiments(37), were important contributors
to the observations made in the present study. Isolated muscle
preparations are often compromised by non-physiological
operating temperatures or by oxygen delivery impaired by
low oxygen-carrying capacity of crystalline perfusate and
limited perfusion into large muscle bundles in vitro (38) and
by abnormal accumulation of metabolites and electrolytes in
the absence of perfusion. These methodological deficiencies
could, therefore, explain the failure of an earlier study to
observe the effects of dietary LC n-3 PUFA-induced
changes in membrane composition on skeletal muscle
function in vitro, except in relation to an essential fatty
acid-deficient diet(13).
Fish oil feeding leads to the incorporation of LC n-3 PUFA
DHA into the hindlimb skeletal muscle(14). This is the principal
n-3 PUFA incorporated into excitable tissues, including heart
and skeletal muscles in humans and animals(34), even when
high-EPA fish oil or purified EPA is consumed(7,9,39). The simi-
larities between the effects of fish oil on skeletal muscle and
myocardial function and fatty acid composition suggest
common underlying mechanisms. In the present study, the
rise time and fall time of force production were found to be
not slowed in the muscle of the n-3 PUFA group to the
same extent as in that of the SF and n-6 PUFA groups. There-
fore, the Ca2þ cycling process appears to be one potential
mechanism of action of fish oil fatty acids in the function of



































































Fig. 3. Effect of dietary fat on contractile function over time in the gastrocne-
mius–plantaris–soleus muscle bundle during 30 min repetitive sciatic nerve
stimulation bouts (2 Hz, 7–12 V, 0·05 ms). (a) Relative rise time (time to
increase from 10 to 90 % maximum developed tension), (b) fall time (time to
decrease from 90 to 10 % maximum tension) and (c) contraction duration
(at 50 % maximum tension). Values are means (n 6 per group), with their
standard errors represented by vertical bars which are omitted when smaller
than the symbol. * Mean values were significantly different between the diet-
ary groups (P,0·05). † Mean values were significantly different within the
dietary groups over time (P,0·05). , Saturated fat diet; , n-6 PUFA diet;
, n-3 PUFA diet.

















excitable cells that may translate to skeletal muscle. Interest-
ingly, the higher unsaturation index of skeletal muscle mem-
brane phospholipids derived from dietary fish oil implies an
increased risk of cellular oxidative damage, which might be
expected to translate into poor contractile performance in
line with the free-radical theory of fatigue(40). However, similar
to exercise training, which puts muscles under increased oxi-
dative stress, yet preconditions against subsequent stress-
induced cellular damage, the paradoxical fatigue resistance
provoked by dietary fish oil suggests that similar to ischaemic
preconditioning(41) and nutritional preconditioning by LC n-3
PUFA in the heart(36) or exercise training(42), the LC n-3 PUFA
up-regulate endogenous protective mechanisms in skeletal
muscle. However, future research will need to specifically
address these aspects.
There was no evidence in the present study that diet-
induced differences in substrate accumulation consistent
with vigorous exercise were responsible for the observed
contractile changes. Lactate production increased as muscles
fatigued; however, as the venous concentrations were greatest
in the n-3 PUFA tissues that fatigued least, these results
support the assertion that lactate and hydrogen ion (Hþ)
accumulation is not a major cause of fatigue(38). Rather, lactate
production, and subsequent decrease in pH, simply reflects
the sustained contractile function of muscles and a greater
extent of anaerobic metabolism(43). In turn, such changes to
local metabolic conditions can enhance oxygen extraction as
observed in fish oil-fed rats during the later phase of fatigue
through a rightward shift in the oxygen–Hb dissociation
curve, permitting greater oxygen unloading in the n-3 PUFA
skeletal muscle, despite provision of a constant blood flow
and arterial PO2. These results also further reflect the tight
coupling of oxygen supply and demand where the efficient
use of oxygen, in muscles with high DHA concentrations,
will ultimately result in more prolonged and sustained force
development.
A number of further questions can be explored with regard
to the role of DHA in skeletal muscle membranes and fatigue.
To date, studies on muscle contraction have been limited
to twitch conditions. Although this is important for under-
standing a basic level of interaction between DHA and
muscle function, there is further need to investigate the role
of fish oil under physiologically relevant conditions of inter-
mittent tetanic muscle contractions that demand a greater
turnover of intracellular calcium. It is also intriguing to postu-
late that possible dietary fish oil preconditioning in skeletal
muscle may allow preparation for stressful conditions where
oxygen delivery may be depressed, such as hypoxia or per-
ipheral ischaemia. Equally, given that epidemiological data
now support the role of LC n-3 PUFA in the diet with respect
to indices of maintained muscle function(44), there is good
reason to further explore the potential for enhanced muscle
physiology or simply attenuated decline by increasing DHA
content in human diets. Most importantly, ‘low-dose’ fish oil,
independent of background n-6 PUFA concentrations, can
achieve equivalent membrane DHA incorporation in skeletal
muscle(45), and this concentration is more than achievable in
human diets (one to two meals of fatty fish per week).
In summary, using the rat in vivo autologous pump-
perfused hindlimb model, in the present study, it was found
that muscles sustained higher repeated contractile force after
fish oil supplementation, which was objectively measured as
an increased time to fatigue. Modulation of skeletal muscle
oxygen consumption was evident across multiple time
points through the fatigue process, associated with increased
membrane DHA concentrations. With the exclusion of cardiac
and vascular mechanisms that affect oxygen delivery, the
increased oxygen efficiency coupled with attenuation of the
fatigue-related prolongation of twitch duration and slowed
recovery to baseline from peak twitch force points towards
improved handling of calcium in the skeletal muscle cells.
The present findings demonstrate that DHA is incorporated
into skeletal muscle membranes to provide direct nutritional
preconditioning to sustain muscle contractile performance.
Preconditioning and improved muscle function have tradition-
ally been associated with exercise training stimulus. However,
in populations with skeletal muscle dysfunction precluding
exercise training, such as the frail and elderly, the revelation
of these potential benefits of dietary LC n-3 PUFA is exciting
and points to future human applications.
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